Excelsior Medical Co. Ltd. (4104) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Excelsior Medical Co. Ltd. (4104:TWSE), powered by AI.

Current Price
$69.60
Sector
Healthcare
What is the Excelsior Medical Co. Ltd. stock price forecast?

Excelsior Medical Co. Ltd. is currently trading at $69.60. View real-time AI analysis on Alpha Lenz.

What is Excelsior Medical Co. Ltd. insider trading activity?

View the latest insider trading data for Excelsior Medical Co. Ltd. on Alpha Lenz.

What is Excelsior Medical Co. Ltd.'s P/E ratio?

View Excelsior Medical Co. Ltd.'s valuation metrics on Alpha Lenz.

Excelsior Medical Co. Ltd.

TWSE · 4104
NT$69.60-0.10(-0.14%)
Ask about Excelsior Medical Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Excelsior Medical Co. Ltd.'s ROE is 8.9%. Explore profitability and growth together.

Ask for details

Company Overview

Excelsior Medical Co. Ltd. is a prominent player in the healthcare and pharmaceutical sector, specializing in the research, development, and marketing of medical devices and pharmacological solutions. With a focus on innovation, the company aims to improve patient care and outcomes by providing high-quality, cost-effective medical products. Excelsior Medical's product range includes diagnostic equipment, therapeutic devices, and a variety of pharmaceutical products that address critical health needs. They serve multiple industries such as hospitals, clinics, and pharmacies, significantly contributing to the healthcare supply chain. Their commitment to research and development ensures that they remain at the forefront of technology in the medical field. By adhering to stringent quality standards, Excelsior Medical Co. Ltd. plays a crucial role in enhancing healthcare delivery systems globally. As a part of the broader healthcare ecosystem, the company’s operations and advancements not only support patient welfare but also influence healthcare practices and policies worldwide.

SectorHealthcare
IndustryMedical Distribution
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$8.79BRevenue
0.00Shares Out
0Employees

Margins

21.33%Gross
16.36%EBITDA
8.25%Operating
13.45%Pre-Tax
10.99%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

6.94%Rev 3Yr
5.66%Rev 5Yr
5.33%Op Inc 3Yr
6.40%Op Inc 5Yr
7.13%Net Inc 3Yr
7.61%Net Inc 5Yr

Returns

4.91%ROA
8.87%ROE
6.19%ROIC

Financial Health

NT$2.85BCash & Cash Equivalents
NT$4.41BNet Debt
61.86%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Excelsior Medical Co. Ltd. (ticker: 4104) is a company listed on TWSE in the Healthcare sector (Medical Distribution).

The current price is 69.6 with a P/E ratio of -x and P/B of -x.

ROE is 8.87% and operating margin is 8.25%. Annual revenue is $8.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Excelsior Medical Co. Ltd. (4104) Stock Forecast 2026 $69.60 — Price, Financials & Analyst Targets | Alpha Lenz